Tag

Nasopharyngeal Carcinoma

All articles tagged with #nasopharyngeal carcinoma

health2 days ago•56 min saved

Flight ear trouble uncovers rare cancer in a 22-year-old California mom

A Hemet, California, 22-year-old mother named Aida Burkins was told her hearing issues and throat bleeding were altitude sickness after a flight; months later she was diagnosed with nasopharyngeal carcinoma, a rare head-and-neck cancer, and is undergoing chemotherapy and radiation. With two young children aged 1 and 3, she remains hopeful the cancer will shrink and she’ll be cancer-free, underscoring the importance of accurate diagnosis.

via Yahoo|

#california #cancer #health

health3 days ago•52 min saved

Flight-ear issue uncovers rare nasopharyngeal cancer in a 22-year-old mom

A 22-year-old California mom of two noticed her ears wouldn’t pop after a flight, then developed hearing loss and throat bleeding. After months of evaluation, she was diagnosed with nasopharyngeal carcinoma, a rare cancer at the upper throat/base of the skull. She underwent chemotherapy and radiation and is finishing treatment with a hopeful prognosis, using her story to remind others that cancer can affect anyone.

via Yahoo|

#cancer #health #hearing-loss

health4 days ago•54 min saved

Ear blockage after a flight leads to a life-changing NPC diagnosis

A 22-year-old California woman’s ear wouldn’t pop after a May 2025 flight, triggering months of symptoms that were initially dismissed as altitude sickness. A mass blocking her nasopharynx was later diagnosed as nasopharyngeal carcinoma (NPC), a rare cancer in the U.S. associated with Epstein-Barr virus. After biopsies and imaging, she began chemotherapy and radiation and is nearing the end of treatment, with doctors optimistic that the cancer is shrinking and she may be cancer-free.

via Yahoo|

#ear #epstein-barr-virus #health

health4 days ago•24 min saved

Unpopped ears on a flight trigger rare cancer diagnosis for California mom

A Hemet, California woman, 22-year-old Aida Burkins, began with ears that wouldn’t pop on a flight to Chicago, but months of medical visits and bleeding led to a nasopharyngeal carcinoma diagnosis. After chemotherapy and radiation, the tumor has shrunk and doctors are hopeful she’ll be cancer-free, underscoring that cancer can affect people of any age.

via New York Post|

#california #cancer #ears

healthcare2 years ago•0 min saved

FDA Approves Toripalimab for Nasopharyngeal Carcinoma Treatment

The FDA has approved toripalimab, a PD-1 inhibitor developed by Junshi Biosciences, for the treatment of recurrent or metastatic nasopharyngeal carcinoma (NPC) in the US market. Coherus BioSciences holds the rights for the drug in the US and Canada and plans to launch it under the brand name Loqtorzi in the first quarter of 2024.

via Endpoints News|

#coherus-biosciences #fda #healthcare

healthcare2 years ago•23 min saved

FDA Approves LOQTORZI™ for All Stages of Nasopharyngeal Carcinoma Treatment

Coherus BioSciences and Junshi Biosciences have announced that the U.S. Food and Drug Administration (FDA) has approved LOQTORZI™ (toripalimab-tpzi) for the treatment of recurrent or metastatic nasopharyngeal carcinoma (NPC). LOQTORZI is the first and only FDA-approved treatment for NPC and can be used in combination with chemotherapy for first-line treatment or as monotherapy for patients with disease progression on or after platinum-containing chemotherapy, regardless of PD-L1 status. The approval was based on positive results from Phase 2 and Phase 3 studies, which showed significant improvements in progression-free survival and overall survival. LOQTORZI is a next-generation PD-1 monoclonal antibody that activates the immune system to kill tumors.

via Yahoo Finance|

#coherus-biosciences #fda-approval #healthcare